Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanguard Extended Market ETF (NY:VXF)

210.14 +0.80 (+0.38%)
Streaming Delayed Price Updated: 3:47 PM EDT, Oct 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vanguard Extended Market ETF

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Why Is Fortress Biotech Stock Falling Today?
Via Stocktwits
Predictive Oncology Stock Receives Significant Investor Interest Today – Here Are Two Important Developments
Via Stocktwits
Kala Bio Stock Just Plunged 92% Today – Here’s What Happened
The firm stated that its KPI-012 failed in a mid-stage clinical trial and announced that it intends to preserve cash, including by laying off some of its workforce and deploying other cost-saving... 
Via Stocktwits
Topics Workforce
Dogwood Therapeutics Stock Soars Pre-Market On Securing License For Cancer-Related Pain Management Drug
In return for the license, Sepin Pharma and its designated affiliates will get 7.31% of Dogwood’s common stock, on a fully diluted basis. 
Via Stocktwits
GUTS Stock Rallied About 28% Today – Here’s Why
Via Stocktwits
bioAffinity Technologies Stock Surged A Whopping 56% Today – Here’s An Important Update
Via Stocktwits
Predictive Oncology Shares Tumble 19% On Reverse Stock Split Announcement – More Details Inside
Via Stocktwits
TNF Pharmaceuticals Stock More Than Doubles After Announcing Name Change To Represent Pivot Into Quantum-Class Computing
Via Stocktwits
Why Did NanoVibronix Stock Jump A Whopping 74% Today?
Via Stocktwits
Helius Medical Stock Rockets 169% After Company Raises $500M To Make Solana Its Primary Treasury Asset: Retail Cheers The Deal
Via Stocktwits
Robinhood Draws Wall Street Praise Over Launch Of New Social Media Platform At HOOD Summit – More Details Inside
Barclays analyst Benjamin Budish noted that Robinhood is accelerating the rollout of features, describing the updates as modern and user-friendly. 
Via Stocktwits
Topics Artificial Intelligence Economy
BioXcel Stock Shoots Up 3% Pre-Market After Company Announces Positive Efficacy Data For Agitation Drug In Study
Via Stocktwits
Professional Diversity Network Stock Exploded Over 400% Today – Here’s An Update
Via Stocktwits
BioXcel’s Sublingual Film Well-Tolerated In Bipolar, Schizophrenia Trial In At-Home Settings, Retail Says Buy Now Or Regret Later
Via Stocktwits
Soho House Nears $9-Share Go-Private Deal: Report
Via Stocktwits
Workhorse Group To Merge With Motive Electric Trucks: Retail’s Divided On The Combined Company Valuation
The combination will create a leading North American medium-duty electric truck original equipment manufacturer with a full range of Class 4-6 trucks valued at about $105 million, the companies said. 
Via Stocktwits
Topics Electric Vehicles
Imunon Doses First Patient With Experimental Cancer Drug In Late-Stage Trial: Retail Thinks Company Is Undervalued
Via Stocktwits
American Airlines Sparks Investor Debate After Q2 Beat, Cautious Outlook: Retail’s On Buying Spree
Via Stocktwits
Wendy's Announces 190 New Burger Chain Outlets In Italy and Armenia: Retail View Turns Bullish
Via Stocktwits
Stitch Fix Surges After William Blair Upgrade: Retail Still On The Fence
Via Stocktwits
Verb Technology Stock Nearly Doubles On Monday, Retail Chatter Explodes A Whopping 1,100%: Here’s What’s Happening
Following the closing of a private placement, expected on or around August 7, the company will operate under the name TON Strategy Co. (TSC). 
Via Stocktwits
Sonnet BioTherapeutics Stock Jumps 82% After Deal With Rorschach I: Retail Stays Exuberant
Via Stocktwits
Robinhood CEO Reportedly Defends OpenAI, SpaceX Tokens – Says Equity Is Not ‘Entirely Relevant’
Robinhood CEO Vlad Tenev defended offering stock tokens for OpenAI and SpaceX, saying equity status is secondary to giving retail investors access. 
Via Stocktwits
Topics ETFs Government
BofA Lowers Crocs Price Target, But Keeps 'Buy' Rating On Potential Upside In Foreign Market
Crocs' Q1 revenue and profit for the last quarter were above expectations, but the company withdrew its full-year 2025 outlook in May. 
Via Stocktwits
Topics World Trade
Robinhood Launches Tokens For EU Users To Trade US Stocks
Robinhood is expanding into Europe with tokenized stocks, crypto futures, and staking, aiming to merge traditional and digital assets through a mobile-first, blockchain-powered investment platform. 
Via Stocktwits
Topics Derivatives ETFs Lawsuit
Cineverse Stock Soars As Terrifier 3 Lifts Q4 Revenue: Retail Optimism Abounds
Cineverse Q4 revenue jumped 58% to $15.6 million, driven by Terrifier 3, with EPS and EBITDA exceeding expectations. 
Via Stocktwits
Topics Artificial Intelligence Government
Cyngn Stocks Soars On Nvidia Partnership, Robotics Showcase
The collaboration showed off Cyngn’s integration of the Nvidia Isaac robotics platform to advance its autonomous vehicle technology tailored for industrial environments. 
Via Stocktwits
Topics Artificial Intelligence Earnings
Sonim Technologies Stock Surges On AI Merger Plans With HPC Firm: Retail Turns Optimistic
Shareholders of the AI infrastructure company would control a majority interest in the combined organization, while Sonim investors would retain equity worth approximately $17.5 million. 
Via Stocktwits
Topics Artificial Intelligence
Nektar Therapeutics Announces Positive Data From Eczema Drug In Mid-stage Trial: Stock More Than Doubles But Retail Sees It Rising Further
Nektar Therapeutics said its mid-stage trial showed that patients who received Rezpegaldesleukin demonstrated improvement in eczema area and severity score compared to placebo at week 16. 
Via Stocktwits
Topics Economy Government
Cidara Therapeutics’ Market Cap Doubles After Investigational Drug Shows Positive Results In Preventing Influenza In Mid-stage Trial
Single doses of 450mg, 300mg, and 150mg of CD388 conferred 76%, 61%, and 58% protection, respectively, from symptomatic influenza over 24 weeks compared to placebo, the company said. 
Via Stocktwits
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.